NANOVIRICIDES, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $2.8M | $13.4M | $2.6M |
| FY2020 | $2.2M | $23.9M | $13.7M |
| FY2021 | $351.1K | $30.3M | $20.5M |
| FY2022 | $412.8K | $23.5M | $14.1M |
| FY2023 | $2.0M | $16.9M | $8.1M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2019 | $2.8M | $13.4M | $2.6M |
| FY2020 | $2.2M | $23.9M | $13.7M |
| FY2021 | $351.1K | $30.3M | $20.5M |
| FY2022 | $412.8K | $23.5M | $14.1M |
| FY2023 | $2.0M | $16.9M | $8.1M |